Dr Reddy’s Laboratories announces the voluntary recall of six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg in the US due to powder discolouration, leading to decreased potency. Elevated Phenylalaninemia (Phe) levels pose risks of permanent neurocognitive deficits. The company urges consumers to contact physicians and return affected lots promptly.
Dr Reddy’s Laboratories Ltd has initiated a voluntary recall of six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg in the U.S. This recall comes as a result of powder discolouration observed in some packets, leading to decreased potency of the medication.
The reduced efficacy of the product poses a risk of elevated Phenylalaninemia (Phe) levels in patients. Chronic elevation of Phe levels, particularly in infants and children, is associated with permanent neurocognitive deficits such as intellectual disability, developmental delay, and seizures.
Moreover, elevated Phe levels during pregnancy, especially in early gestation, may lead to complications such as microcephaly and congenital heart disease.
Dr Reddy’s Laboratories Inc., the US-based subsidiary, has not received any adverse event reports related to this recall. However, consumers are urged to examine their inventory of the affected product and quarantine any recalled lots immediately.
Additional Read: Share Market News
The company advises consumers to consult their physician before discontinuing the use of the medication. Additionally, consumers are instructed to return the recalled product to their place of purchase.
The recall underscores the importance of quality control in pharmaceutical products to ensure the safety and efficacy of medications for patients.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Best Ethanol Stocks In India
19 May, 2024 | 3 Min. read
JSW Steel Q4 Results: Q4 Profit falls to ₹1,322 Crore
18 May, 2024 | 4 Min. read
Explore Best EV Stocks in India
18 May, 2024 | 3 Min. read
Most Volatile Stocks in India: How to Identify Them?
18 May, 2024 | 4 Min. read
Top AI Stocks in India: Investing in the Future of Tech
18 May, 2024 | 4 Min. read
Best Indicators For Intraday Trading
18 May, 2024 | 4 Min. read
Gold Rate Today | Gold Dips 0.3% Despite Strong Dollar
17 May, 2024 | 2 Min. read
Commodities Market Today | Oil Prices Rise on Stockpile Drop
17 May, 2024 | 1 Min. read
Share Market Today | Gift Nifty Strong, Dow Hits 40k Mark
17 May, 2024 | 5 Min. read
M&M to Invest ₹12,000 Cr in EV Unit, Mahindra Electric Automobile Ltd
17 May, 2024 | 3 Min. read
eClerx Services Approves ₹385 Cr Buyback at 16% Premium
17 May, 2024 | 3 Min. read
Adani Ports Out of Norwegian Central Bank’s Pension Fund
17 May, 2024 | 3 Min. read
Analysis to Become a Pro Investor
28 Dec, 2023 | 4 Min. read
Women In Real Estate Investing (Investree)
28 Dec, 2023 | 5 Min. read
How To Check Prudent Corporate Advisory IPO Allotment Status
27 Dec, 2023 | 3 Min. read
How To Boost Credit Score? – Steps to Improve Creditworthiness
27 Dec, 2023 | 4 Min. read
Advantages and Disadvantages of Opening Multiple Demat Accounts
26 Dec, 2023 | 4 Min. read
7th CPC LTC: Leave Travel Concession Rules for Central Government Employees
26 Dec, 2023 | 4 Min. read
7th Pay Commission: House Building Advance (HBA) Interest Rate FY 2023-24
26 Dec, 2023 | 5 Min. read
The Future of Trading: Exploring Bajaj Broking’s Demat Features
26 Dec, 2023 | 6 Min. read
7th Central Pay Commission Cpc Fitment Table
23 Dec, 2023 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading